A Phase II Study of Efficacy and Safety in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma
Clinical trial NCT01327053 · COMPLETED
Trial details
- NCT number
- NCT01327053
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-29
- Primary completion
- 2013-06-28
- Enrollment
- 230
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.